Defining the optimal spirometry cut-off points for optimal bronchodilator response in prematurity-associated lung disease.
John Lowe, Michael Cousins, Kylie Hart, Sarah J Kotecha, W John Watkins, Sailesh Kotecha
原始摘要（英文原文）· Original abstract
The best approach to identification and management of prematurity-associated lung disease is uncertain. This study describes a method for identification of at-risk children who may be amenable to inhaled therapy. https://bit.ly/4vvvyR9.